Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Harrow, Inc.(HROW) | 3,795,000 | 3,820,000 | +25,000 | $54.53M | $42.78M | 11.38% | -$11.75M |
| TG Therapeutics, Inc.(TGTX) | 1,890,000 | 2,215,000 | +325,000 | $15.80M | $37.83M | 10.06% | +$22.03M |
| Acelyrin Inc | 4,146,138 | 4,146,138 | 0 | $42.17M | $30.93M | 8.22% | -$11.24M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 653,000 | 610,000 | -43,000 | $14.97M | $28.04M | 7.46% | +$13.07M |
| Ocular Therapeutix, Inc.(OCUL) | 6,468,000 | 6,070,000 | -398,000 | $20.31M | $27.07M | 7.20% | +$6.76M |
| Catalyst Pharmaceuticals Inc | 1,205,000 | 1,257,200 | +52,200 | $14.09M | $21.44M | 5.70% | +$7.35M |
| Keros Therapeutics, Inc.(KROS) | 360,400 | 357,500 | -2,900 | $11.49M | $14.21M | 3.78% | +$2.72M |
| IDEAYA Biosciences, Inc.(IDYA) | 311,500 | 311,500 | 0 | $8.40M | $11.08M | 2.95% | +$2.68M |
| Eton Pharmaceuticals, Inc.(ETON) | 2,430,270 | 2,529,887 | +99,617 | $10.13M | $11.08M | 2.95% | +$946.7K |
| Crinetics Pharmaceuticals Inc | 370,000 | 307,500 | -62,500 | $11.00M | $10.94M | 2.91% | -$63.0K |
| Arvinas, Inc.(ARVN) | 0 | 263,700 | +263,700 | $0 | $10.85M | 2.89% | +$10.85M |
| Codexis, Inc.(CDXS) | 1,118,900 | 3,045,525 | +1,926,625 | $2.11M | $9.29M | 2.47% | +$7.17M |
| Biohaven Ltd.(BHVN) | 439,000 | 200,000 | -239,000 | $11.42M | $8.56M | 2.28% | -$2.86M |
| Edgewise Therapeutics, Inc.(EWTX) | 875,405 | 699,000 | -176,405 | $5.02M | $7.65M | 2.03% | +$2.63M |
| Iovance Biotherapeutics, Inc.(IOVA) | 610,000 | 897,000 | +287,000 | $2.78M | $7.29M | 1.94% | +$4.52M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 0 | 1,960,000 | +1,960,000 | $0 | $6.33M | 1.68% | +$6.33M |
| 4d Molecular Therapeutics Inc | 308,500 | 308,500 | 0 | $3.93M | $6.25M | 1.66% | +$2.32M |
| Marinus Pharmaceuticals Inc | 584,000 | 563,500 | -20,500 | $4.70M | $6.13M | 1.63% | +$1.42M |
| Vaxcyte, Inc.(PCVX) | 90,000 | 90,000 | 0 | $4.59M | $5.65M | 1.50% | +$1.06M |
| Liquidia Corporation(LQDA) | 570,700 | 445,000 | -125,700 | $3.62M | $5.35M | 1.42% | +$1.74M |
| Protara Therapeutics, Inc.(TARA) | 2,692,594 | 2,692,594 | 0 | $4.50M | $5.05M | 1.34% | +$552.3K |
| UroGen Pharma Ltd.(URGN) | 320,000 | 320,000 | 0 | $4.48M | $4.80M | 1.28% | +$316.8K |
| Xoma Corp Del | 274,500 | 250,000 | -24,500 | $3.87M | $4.63M | 1.23% | +$757.3K |
| Applied Therapeutics | 893,000 | 1,092,500 | +199,500 | $2.22M | $3.66M | 0.97% | +$1.44M |
| Relmada Therapeutics, Inc.(RLMD) | 30,000 | 877,000 | +847,000 | $90.0K | $3.63M | 0.97% | +$3.54M |
| Biodesix, Inc.(BDSX) | 455,573 | 496,500 | +40,927 | $3.04M | $3.61M | 0.96% | +$572.4K |
| Trevi Therapeutics, Inc.(TRVI) | 1,705,900 | 2,535,000 | +829,100 | $3.72M | $3.40M | 0.90% | -$322.0K |
| Jasper Therapeutics, Inc.(JSPR) | 0 | 3,985,340 | +3,985,340 | $0 | $3.14M | 0.84% | +$3.14M |
| Intellia Therapeutics, Inc.(NTLA) | 0 | 99,000 | +99,000 | $0 | $3.02M | 0.80% | +$3.02M |
| Newamsterdam Pharma Company ORDINARY SHARES | 0 | 265,388 | +265,388 | $0 | $2.96M | 0.79% | +$2.96M |
| Gossamer Bio, Inc.NOTE 5 000 6 0(GOSS) | 8,000,000 | 0 | -8,000,000 | $3.10M | $2.92M | 0.78% | -$183.6K |
| Larimar Therapeutics, Inc.(LRMR) | 848,500 | 623,500 | -225,000 | $3.35M | $2.84M | 0.75% | -$514.6K |
| Ventyx Biosciences Inc | 0 | 1,140,000 | +1,140,000 | $0 | $2.82M | 0.75% | +$2.82M |
| Syros Pharmaceuticals Inc | 0 | 359,370 | +359,370 | $0 | $2.80M | 0.74% | +$2.80M |
| Gossamer Bio, Inc.(GOSS) | 4,754,200 | 2,982,200 | -1,772,000 | $3.96M | $2.72M | 0.72% | -$1.24M |
| Protagonist Therapeutics Inc | 0 | 112,700 | +112,700 | $0 | $2.58M | 0.69% | +$2.58M |
| Kalvista Pharmaceuticals Inc | 500,000 | 150,000 | -350,000 | $4.82M | $1.84M | 0.49% | -$2.98M |
| Verastem, Inc.(VSTM) | 211,400 | 211,400 | 0 | $1.72M | $1.72M | 0.46% | +$2.1K |
| Nyxoah S ASHS SHS | 441,896 | 344,800 | -97,096 | $3.12M | $1.60M | 0.43% | -$1.52M |
| Morphosys AgADS | 1,209,380 | 145,000 | -1,064,380 | $8.13M | $1.44M | 0.38% | -$6.69M |
| Precigen, Inc.(PGEN) | 928,500 | 1,012,500 | +84,000 | $1.32M | $1.36M | 0.36% | +$38.3K |
| Sutro Biopharma, Inc.(STRO) | 0 | 301,491 | +301,491 | $0 | $1.29M | 0.34% | +$1.29M |
| Context Therapeutics Inc.(CNTX) | 0 | 975,000 | +975,000 | $0 | $1.10M | 0.29% | +$1.10M |
| Fulcrum Therapeutics, Inc.(FULC) | 0 | 130,000 | +130,000 | $0 | $877.5K | 0.23% | +$877.5K |
| Aligos Therapeutics Inc | 0 | 1,297,000 | +1,297,000 | $0 | $861.2K | 0.23% | +$861.2K |
| Kiniksa Pharmaceuticals LtdCL A | 0 | 37,500 | +37,500 | $0 | $640.2K | 0.17% | +$640.2K |
| FORTRESS BIOTECH INCCOM(FBIO) | 2,000,000 | 0 | -2,000,000 | $580.6K | $0 | — | -$580.6K |
| GERON CORPCOM(GERN) | 1,915,000 | 0 | -1,915,000 | $4.06M | $0 | — | -$4.06M |
| IGM BIOSCIIENCES INCCOM | 261,000 | 0 | -261,000 | $2.18M | $0 | — | -$2.18M |
| KEZAR LIFE SCIENCES INCCOM | 425,000 | 0 | -425,000 | $505.8K | $0 | — | -$505.8K |
| TELA BIO INCCOM(TELA) | 750,000 | 0 | -750,000 | $6.00M | $0 | — | -$6.00M |
| TRACON PHARMACEUTICALS INCCOM NEW | 4,764,508 | 0 | -4,764,508 | $848.1K | $0 | — | -$848.1K |
| XERIS BIOPHARMA HOLDINGS INCCOM | 390,000 | 0 | -390,000 | $725.4K | $0 | — | -$725.4K |